Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]

Richard Moreau¹, Joan Clària², Ferran Aguilar³, François Fenaille⁴, Juan José Lozano⁵, Christophe Junot⁴, Benoit Colsch⁴, Paolo Caraceni⁶, Jonel Trebicka⁷, Marco Pavesi³, Carlo Alessandria⁸, Frederik Nevens⁹, Faouzi Saliba¹⁰, Tania M Welzel¹¹, Agustin Albillos¹², Thierry Gustot¹³, Javier Fernández², Christophe Moreno¹³, Maurizio Baldassarre⁶, Giacomo Zaccherini⁶, Salvatore Piano¹⁴, Sara Montagnese¹⁴, Victor Vargas¹⁵, Joan Genescà¹⁵, Elsa Solà¹⁶, William Bernal¹⁷, Noémie Butin⁴, Thaïs Hautbergue⁴, Sophie Cholet⁴, Florence Castelli⁴, Christian Jansen¹⁸, Christian Steib¹⁹, Daniela Campion⁸, Raj Mookerjee²⁰, Miguel Rodríguez-Gandía¹², German Soriano²¹, François Durand²², Daniel Benten²³, Rafael Bañares²¹, Rudolf E Stauber²⁴, Henning Gronbaek²⁵, Minneke J Coenraad²⁶, Pere Ginès¹⁶, Alexander Gerbes¹⁹, Rajiv Jalan²⁰, Mauro Bernardi⁶, Vicente Arroyo³, Paolo Angeli²⁷; CANONIC Study Investigators of the EASL Clif Consortium; Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif)

Affiliations

¹ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), UMRS1149, Université de Paris, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France. Electronic address: richard.moreau@inserm.fr.
² EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Hospital Clínic-IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBERehd, Barcelona, Spain.
³ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain.
⁴ Service de Pharmacologie et Immuno-Analyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France.
⁵ CIBERehd, Barcelona, Spain.
⁶ Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
⁷ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; J.W. Goethe University Hospital, Frankfurt, Germany.
⁸ Division of Gastroenterology and Hepatology, San Giovanni Battista Hospital, Torino, Italy.
⁹ University Hospital Gasthuisberg, KU Leuven, Belgium.
¹⁰ Hôpital Paul Brousse, Université Paris-Sud, Villejuif, France.
¹¹ J.W. Goethe University Hospital, Frankfurt, Germany.
¹² Hospital Ramón y Cajal, Madrid, Spain.
¹³ CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
¹⁴ Unit of Internal Medicine and Hepatology, Dept. of Medicine, DIMED, University of Padova, Italy.
¹⁵ Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
¹⁶ Hospital Clínic-IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBERehd, Barcelona, Spain.
¹⁷ Liver Intensive Therapy Unit, Institute of Liver Studies, Division of Inflammation Biology, King's College London, London, UK.
¹⁸ Department of Internal Medicine I, University of Bonn, Germany.
¹⁹ Department of Medicine II, Liver Center Munich, University Hospital LMU Munich, Munich, Germany.
²⁰ Liver Failure Group, Institute for Liver Disease Health, University College London, Royal Free Hospital, London, UK.
²¹ Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
²² Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), UMRS1149, Université de Paris, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
²³ University Hospital Hamburg-Eppendorf, Germany.
²⁴ Medical University of Graz, Graz, Austria.
²⁵ Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
²⁶ Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
²⁷ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Unit of Internal Medicine and Hepatology, Dept. of Medicine, DIMED, University of Padova, Italy.

PMID: 32192825
DOI: 10.1016/j.jhep.2020.03.002

Published Erratum

Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]

Richard Moreau et al. J Hepatol. 2020 Jun.

. 2020 Jun;72(6):1218-1220.

doi: 10.1016/j.jhep.2020.03.002. Epub 2020 Mar 17.

Authors

Affiliations

¹ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), UMRS1149, Université de Paris, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France. Electronic address: richard.moreau@inserm.fr.
² EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Hospital Clínic-IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBERehd, Barcelona, Spain.
³ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain.
⁴ Service de Pharmacologie et Immuno-Analyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France.
⁵ CIBERehd, Barcelona, Spain.
⁶ Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
⁷ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; J.W. Goethe University Hospital, Frankfurt, Germany.
⁸ Division of Gastroenterology and Hepatology, San Giovanni Battista Hospital, Torino, Italy.
⁹ University Hospital Gasthuisberg, KU Leuven, Belgium.
¹⁰ Hôpital Paul Brousse, Université Paris-Sud, Villejuif, France.
¹¹ J.W. Goethe University Hospital, Frankfurt, Germany.
¹² Hospital Ramón y Cajal, Madrid, Spain.
¹³ CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
¹⁴ Unit of Internal Medicine and Hepatology, Dept. of Medicine, DIMED, University of Padova, Italy.
¹⁵ Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
¹⁶ Hospital Clínic-IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBERehd, Barcelona, Spain.
¹⁷ Liver Intensive Therapy Unit, Institute of Liver Studies, Division of Inflammation Biology, King's College London, London, UK.
¹⁸ Department of Internal Medicine I, University of Bonn, Germany.
¹⁹ Department of Medicine II, Liver Center Munich, University Hospital LMU Munich, Munich, Germany.
²⁰ Liver Failure Group, Institute for Liver Disease Health, University College London, Royal Free Hospital, London, UK.
²¹ Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
²² Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), UMRS1149, Université de Paris, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
²³ University Hospital Hamburg-Eppendorf, Germany.
²⁴ Medical University of Graz, Graz, Austria.
²⁵ Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
²⁶ Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
²⁷ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Unit of Internal Medicine and Hepatology, Dept. of Medicine, DIMED, University of Padova, Italy.

PMID: 32192825
DOI: 10.1016/j.jhep.2020.03.002

No abstract available

PubMed Disclaimer

Erratum for

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
Moreau R, Clària J, Aguilar F, Fenaille F, Lozano JJ, Junot C, Colsch B, Caraceni P, Trebicka J, Pavesi M, Alessandria C, Nevens F, Saliba F, Welzel TM, Albillos A, Gustot T, Fernández J, Moreno C, Baldassarre M, Zaccherini G, Piano S, Montagnese S, Vargas V, Genescà J, Solà E, Bernal W, Butin N, Hautbergue T, Cholet S, Castelli F, Jansen C, Steib C, Campion D, Mookerjee R, Rodríguez-Gandía M, Soriano G, Durand F, Benten D, Bañares R, Stauber RE, Gronbaek H, Coenraad MJ, Ginès P, Gerbes A, Jalan R, Bernardi M, Arroyo V, Angeli P; CANONIC Study Investigators of the EASL Clif Consortium; Grifols Chair; European Foundation for the Study of Chronic Liver Failure (EF Clif). Moreau R, et al. J Hepatol. 2020 Apr;72(4):688-701. doi: 10.1016/j.jhep.2019.11.009. Epub 2019 Nov 25. J Hepatol. 2020. PMID: 31778751

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]

Affiliations

Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources